TITLE:
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia

CONDITION:
Schizophrenia

INTERVENTION:
quetiapine fumarate tablets

SUMMARY:

      The purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate
      (SEROQUEL) compared with placebo in the treatment of adolescent patients with schizophrenia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 13 Years to 17 Years
Criteria:

        Inclusion Criteria:

          -  Patient is able to provide written assent and the parents or legal guardian of the
             patient is able to provide written informed consent before beginning and study
             related procedures

          -  Patient has a documented clinical diagnosis of schizophrenia

          -  Patient's parent or legal guardian will be able to accompany the patient at each
             scheduled study visit

        Exclusion Criteria:

          -  Patients (female) must not be pregnant or lactating

          -  Patients with a known intolerance or lack of response to previous treatment with
             quetiapine

          -  Patients who have previously participated in this study
      
